Topical Anti-Nuclear Factor-Kappa B Small Interfering RNA with Functional Peptides Containing Sericin-Based Hydrogel for Atopic Dermatitis

The small interfering RNA (siRNA) is suggested to offer a novel means of treating atopic dermatitis (AD) because it allows the specific silencing of genes related to AD pathogenesis. In our previous study, we found that siRNA targeted against RelA, an important nuclear factor-kappa B (NF-κB) subdoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanazawa, Takanori, Shizawa, Yuki, Takeuchi, Mayu, Tamano, Kuniko, Ibaraki, Hisako, Seta, Yasuo, Takashima, Yuuki, Okada, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588201/
https://www.ncbi.nlm.nih.gov/pubmed/26371030
http://dx.doi.org/10.3390/pharmaceutics7030294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588201/
https://www.ncbi.nlm.nih.gov/pubmed/26371030
http://dx.doi.org/10.3390/pharmaceutics7030294

Ejemplares similares